FDA records indicate that there are no current recalls for this drug.
Are you a medical professional?
Trending Topics
Aveeno Baby Calming Comfort Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
For external use only.
- Do not get into eyes
- Condition worsens
- Symptoms last more than 7 days or clear up and occur again within a few days.
- Deep or puncture wounds
- Animal bites
- Serious burns
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
- Condition worsens
- Symptoms last more than 7 days or clear up and occur again within a few days.
- Deep or puncture wounds
- Animal bites
- Serious burns
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
- Temporarily protects and helps relieve chapped, or cracked skin
History
There is currently no drug history available for this drug.
Other Information
There are no additional details available for this product.
Sources
Aveeno Baby Calming Comfort Manufacturers
-
Johnson & Johnson Consumer Products Company, Division Of Johnson & Johnson Consumer Companies, Inc.
Aveeno Baby Calming Comfort | Clipper Distributing Company Llc
Caution: Operating rooms should be provided with adequate ventilation to prevent the accumulation of anesthetic vapors.
Premedication: A premedication regimen, which may be employed depending upon the patient status, to avert excitement during induction, might include an anticholinergic, a tranquilizer, a muscle relaxant and a short-acting barbiturate.
Inspired Concentration: The delivered concentration of Isoflurane, USP should be known. Isoflurane may be vaporized using a flow-through vaporizer specifically calibrated for isoflurane. Vaporizers delivering a saturated vapor which then is diluted (e.g. Verni-trol® vaporizer) also may be used. The delivered concentration from such a vaporizer may be calculated using the formula:
% isoflurane = 100 PVFV / FT(PA-PV)
Where: PA = Pressure of atmosphere
PV = Vapor pressure of isoflurane
FV = Flow of gas through vaporizer (mL/min)
FT = Total gas flow used (mL/min)Isoflurane contains no stabilizer. Nothing in the drug product alters calibration or operation of these vaporizers.
Induction:
Horses: Inspired concentrations of 3.0 to 5.0% isoflurane alone with oxygen following a barbiturate anesthetic induction are usually employed to induce surgical anesthesia in the horse.
Dogs: Inspired concentrations of 2.0 to 2.5% isoflurane alone with oxygen following a barbiturate anesthetic induction are usually employed to induce surgical anesthesia in the dog.
These concentrations can be expected to produce surgical anesthesia in 5 to 10 minutes.
Maintenance: The concentration of vapor necessary to maintain anesthesia is much less than that required to induce it.
Horses: Surgical levels of anesthesia in the horse may be sustained with a 1.5 to 1.8% concentration of isoflurane in oxygen.
Dogs: Surgical levels of anesthesia in the dog may be sustained with a 1.5 to 1.8% concentration of isoflurane in oxygen.
The level of blood pressure during maintenance is an inverse function of isoflurane concentration in the absence of other complicating problems. Excessive decreases, unless related to hypovolemia, may be due to depth of anesthesia and in such instances may be corrected by lightening the level of anesthesia.
Recovery from isoflurane anesthesia is typically uneventful.2
Login To Your Free Account